These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24626829)

  • 21. Renal inflammatory pseudotumor.
    Bell ND; Gavras JN; Donnell CA; Rodning CB
    South Med J; 1998 Nov; 91(11):1050-3. PubMed ID: 9824189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Refractory myasthenia gravis with good response to rituximab. Report of one case].
    Suárez H F; Urrutia E D
    Rev Med Chil; 2020 Jul; 148(7):1031-1033. PubMed ID: 33399689
    [No Abstract]   [Full Text] [Related]  

  • 23. Rituximab in refractory myasthenia gravis: Extended prospective study results.
    Beecher G; Anderson D; Siddiqi ZA
    Muscle Nerve; 2018 Sep; 58(3):452-455. PubMed ID: 29742795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab and lupus interstitial lung disease: friend or foe?
    Efthimiou P; Kukar M; Hersh A
    Int J Rheum Dis; 2011 Feb; 14(1):e3-4. PubMed ID: 21303472
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
    Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Myasthenia--ocular type].
    Stefanescu AM; Ungureanu E; Tugui A; Gradinaru SL
    Oftalmologia; 2011; 55(4):40-6. PubMed ID: 22642135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective response to rituximab in a young child with MuSK-associated myasthenia gravis.
    Govindarajan R; Iyadurai SJ; Connolly A; Zaidman C
    Neuromuscul Disord; 2015 Aug; 25(8):651-2. PubMed ID: 25998611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brucellosis-induced autoimmune hemolytic anemia treated with rituximab.
    Bourantas LK; Pappas G; Kapsali E; Gougopoulou D; Papamichail D; Bourantas KL
    Ann Pharmacother; 2010 Oct; 44(10):1677-80. PubMed ID: 20823278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inflammatory pseudotumor of the breast. A case report].
    Nori J; Masi A; Vivian A; Di Lollo S; Boeri C
    Radiol Med; 2000 Mar; 99(3):196-8. PubMed ID: 10879173
    [No Abstract]   [Full Text] [Related]  

  • 30. Management challenges in muscle-specific tyrosine kinase myasthenia gravis.
    Evoli A; Alboini PE; Bisonni A; Mastrorosa A; Bartoccioni E
    Ann N Y Acad Sci; 2012 Dec; 1274():86-91. PubMed ID: 23252901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal failure resulting from infiltration by inflammatory myofibroblastic tumor responsive to corticosteroid therapy.
    Williams ME; Longmaid HE; Trey G; Federman M; Crosson AW
    Am J Kidney Dis; 1998 Jun; 31(6):E5. PubMed ID: 10074585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resolution of Hypoprothrombinemia-Lupus Anticoagulant Syndrome (HLAS) after multidrug therapy with rituximab: a case report and review of the literature.
    Paschal RD; Neff AT
    Haemophilia; 2013 Mar; 19(2):e62-5. PubMed ID: 22989209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effectiveness and safety of rituximab in pemphigus vulgaris].
    Alonso Sánchez A; García Rodríguez S; López Avila A; Rabell Iñigo S
    Farm Hosp; 2010; 34(2):98-9. PubMed ID: 20304370
    [No Abstract]   [Full Text] [Related]  

  • 34. Rituximab in late-onset myasthenia gravis is safe and effective.
    Sahai SK; Maghzi AH; Lewis RA
    Muscle Nerve; 2020 Sep; 62(3):377-380. PubMed ID: 32239711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic challenge: Myasthenia gravis in the emergency department.
    Abbott SA
    J Am Acad Nurse Pract; 2010 Sep; 22(9):468-73. PubMed ID: 20854638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
    Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
    J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil.
    Vernino S; Salomao DR; Habermann TM; O'Neill BP
    Neurology; 2005 Aug; 65(4):639-41. PubMed ID: 16116136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab.
    Unal S; Sag E; Kuskonmaz B; Kesici S; Bayrakci B; Ayvaz DC; Tezcan I; Yalnızoglu D; Uckan D
    Pediatr Blood Cancer; 2014 May; 61(5):928-30. PubMed ID: 24307660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral orbital pseudotumor with suprasellar and pulmonary involvement: report of a case.
    Lai YH; Wang HZ; Tsai RK; Hoyt WF; Lee BF
    J Neuroophthalmol; 2000 Dec; 20(4):268-72. PubMed ID: 11130756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment.
    Yi JS; Decroos EC; Sanders DB; Weinhold KJ; Guptill JT
    Muscle Nerve; 2013 Dec; 48(6):992-3. PubMed ID: 24006142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.